1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Product Analysis
3.7 Application Analysis
3.8 End User Analysis
3.9 Emerging Markets
3.10 Impact of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Regenerative Medicine Market, By Product
5.1 Introduction
5.2 Progenitor and Stem Cell Therapies
5.3 Gene Therapies
5.4 Tissue-Engineering
5.5 Cell Therapies
5.6 Other Products
6 Global Regenerative Medicine Market, By Material
6.1 Introduction
6.2 Genetically Engineered Material
6.2.1 Transgenics
6.2.2 Genetically Manipulated Cell
6.2.3 Gene-Activated Matrices
6.2.4 Neural Stem Cell
6.2.5 Three-Dimensional Polymer Technology
6.2.6 Fibroblast
6.3 Synthetic material
6.3.1 Artificial vascular graft material
6.3.2 Hydrogel material
6.3.3 Scaffold
6.4 Biologically derived material
6.4.1 Xenogeneic material
6.4.2 Collagen
6.5 Pharmaceutical
6.5.1 Biologic
7 Global Regenerative Medicine Market, By Application
7.1 Introduction
7.2 Oncology
7.3 Wound Care
7.4 Cardiovascular
7.5 Musculoskeletal
7.6 Ophthalmology
7.7 Other Applications
8 Global Regenerative Medicine Market, By End User
8.1 Introduction
8.2 Government & Academic Research Institutes
8.3 Hospitals & Clinics
8.4 Commercial Industries
9 Global Regenerative Medicine Market, By Geography
9.1 Introduction
9.2 North America
9.2.1 US
9.2.2 Canada
9.2.3 Mexico
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 Italy
9.3.4 France
9.3.5 Spain
9.3.6 Rest of Europe
9.4 Asia Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Australia
9.4.5 New Zealand
9.4.6 South Korea
9.4.7 Rest of Asia Pacific
9.5 South America
9.5.1 Argentina
9.5.2 Brazil
9.5.3 Chile
9.5.4 Rest of South America
9.6 Middle East & Africa
9.6.1 Saudi Arabia
9.6.2 UAE
9.6.3 Qatar
9.6.4 South Africa
9.6.5 Rest of Middle East & Africa
10 Key Developments
10.1 Agreements, Partnerships, Collaborations and Joint Ventures
10.2 Acquisitions & Mergers
10.3 New Product Launch
10.4 Expansions
10.5 Other Key Strategies
11 Company Profiling
11.1 Smith & Nephew plc
11.2 Shenzhen SibionoGeneTech Co., Ltd.
11.3 AstraZeneca
11.4 Aspect Biosystems
11.5 Integra LifeSciences Corporation
11.6 Novartis AG
11.7 Medtronic plc
11.8 Amgen, Inc.
11.9 MiMedx Group
11.10 Baxter
11.11 Eli Lilly & Co.
11.12 Mesoblast Ltd.
11.13 Bayer AG
11.14 Corestem, Inc.
11.15 Bluebird Bio, Inc.
11.16 Regrow Biosciences Pvt. Ltd.
List of Tables
Table 1 Global Regenerative Medicine Market Outlook, By Region (2020-2028) ($MN)
Table 2 Global Regenerative Medicine Market Outlook, By Product (2020-2028) ($MN)
Table 3 Global Regenerative Medicine Market Outlook, By Progenitor and Stem Cell Therapies (2020-2028) ($MN)
Table 4 Global Regenerative Medicine Market Outlook, By Gene Therapies (2020-2028) ($MN)
Table 5 Global Regenerative Medicine Market Outlook, By Tissue-Engineering (2020-2028) ($MN)
Table 6 Global Regenerative Medicine Market Outlook, By Cell Therapies (2020-2028) ($MN)
Table 7 Global Regenerative Medicine Market Outlook, By Other Products (2020-2028) ($MN)
Table 8 Global Regenerative Medicine Market Outlook, By Material (2020-2028) ($MN)
Table 9 Global Regenerative Medicine Market Outlook, By Genetically Engineered Material (2020-2028) ($MN)
Table 10 Global Regenerative Medicine Market Outlook, By Transgenics (2020-2028) ($MN)
Table 11 Global Regenerative Medicine Market Outlook, By Genetically Manipulated Cell (2020-2028) ($MN)
Table 12 Global Regenerative Medicine Market Outlook, By Gene-Activated Matrices (2020-2028) ($MN)
Table 13 Global Regenerative Medicine Market Outlook, By Neural Stem Cell (2020-2028) ($MN)
Table 14 Global Regenerative Medicine Market Outlook, By Three-Dimensional Polymer Technology (2020-2028) ($MN)
Table 15 Global Regenerative Medicine Market Outlook, By Fibroblast (2020-2028) ($MN)
Table 16 Global Regenerative Medicine Market Outlook, By Synthetic material (2020-2028) ($MN)
Table 17 Global Regenerative Medicine Market Outlook, By Artificial vascular graft material (2020-2028) ($MN)
Table 18 Global Regenerative Medicine Market Outlook, By Hydrogel material (2020-2028) ($MN)
Table 19 Global Regenerative Medicine Market Outlook, By Scaffold (2020-2028) ($MN)
Table 20 Global Regenerative Medicine Market Outlook, By Biologically derived material (2020-2028) ($MN)
Table 21 Global Regenerative Medicine Market Outlook, By Xenogeneic material (2020-2028) ($MN)
Table 22 Global Regenerative Medicine Market Outlook, By Collagen (2020-2028) ($MN)
Table 23 Global Regenerative Medicine Market Outlook, By Pharmaceutical (2020-2028) ($MN)
Table 24 Global Regenerative Medicine Market Outlook, By Biologic (2020-2028) ($MN)
Table 25 Global Regenerative Medicine Market Outlook, By Application (2020-2028) ($MN)
Table 26 Global Regenerative Medicine Market Outlook, By Oncology (2020-2028) ($MN)
Table 27 Global Regenerative Medicine Market Outlook, By Wound Care (2020-2028) ($MN)
Table 28 Global Regenerative Medicine Market Outlook, By Cardiovascular (2020-2028) ($MN)
Table 29 Global Regenerative Medicine Market Outlook, By Musculoskeletal (2020-2028) ($MN)
Table 30 Global Regenerative Medicine Market Outlook, By Ophthalmology (2020-2028) ($MN)
Table 31 Global Regenerative Medicine Market Outlook, By Other Applications (2020-2028) ($MN)
Table 32 Global Regenerative Medicine Market Outlook, By End User (2020-2028) ($MN)
Table 33 Global Regenerative Medicine Market Outlook, By Government & Academic Research Institutes (2020-2028) ($MN)
Table 34 Global Regenerative Medicine Market Outlook, By Hospitals & Clinics (2020-2028) ($MN)
Table 35 Global Regenerative Medicine Market Outlook, By Commercial Industries (2020-2028) ($MN)